Applied dna to present at the imperial capital 2020 security investor conference on december 3

Stony brook, n.y.--(business wire)---- $apdn--applied dna sciences, inc. (nasdaq: apdn) (“applied dna” or the "company"), a leader in polymerase chain reaction (pcr)-based dna manufacturing, announced that it is scheduled to participate virtually in the imperial capital 2020 security investor conference on thursday, december 3, 2020. dr. james a. hayward, chief executive officer, will present at 10:45 a.m. est that day and host one-on-one meetings throughout the day. an archived webcast will be available
APDN Ratings Summary
APDN Quant Ranking